Enterprise Value
112.7M
Cash
52.4M
Avg Qtr Burn
-7.779M
Short % of Float
9.45%
Insider Ownership
0.86%
Institutional Own.
21.10%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Defencath Details Infectious disease, Catheter related blood stream infections | Approved Quarterly sales |